US Biological inks antibody labelling deal with Sygnis subsidiary

By Staff Reporter

- Last updated on GMT

GettyImages/Eraxion
GettyImages/Eraxion

Related tags: Molecular biology

Innova Biosciences says its Lightening-Link tech helps customers not to waste expensive reagents in antibody conjugation as it inks a supply deal with US Biological.

The agreement – financials of which have not been divulged – will see Innova, a subsidiary of Germany-headquarterd Sygnis AG, supply bioreagent manufacturer US Biological with its Lightening-Link antibody labelling technology.

Antibodies conjugated to a label (such as an enzyme, fluorescent dye, biotin etc) are used to detect and visualise the presence of a target such as an antigen in a sample, which is required across many areas of research and development,”​ Alastair Carrington, VP of Business Development at Innova told this publication.

The platform is “incredibly simple,”​ according to Carrington: “The researcher just pipettes their antibody or protein into a lyophilized vial of the Lightning-Link label – then incubates for 20 minutes (or 3 hours depending on the label).

“The antibody will be covalently bound to the label, without any further wash or separation steps, and with no loss of antibody or protein.”

And while there are other labelling platforms available, Carrington said the Lightening-Link technology requires no separation or wash steps post conjugation and results in reproducible results.

“There is no antibody or protein loss, which saves customers wasting expensive reagent,”​ he explained. “The kits only require 30 seconds hands-on time, whereas other kits available require laborious multi-step procedures.”

US Biological will use Lightning-Link as its preferred antibody conjugation technology to expand its existing catalogue by enabling the production of additional labels.

Related news

Related products

show more

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 21-May-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

High-Density Vero Cell Perfusion Culture

High-Density Vero Cell Perfusion Culture

Eppendorf for Bioprocess – Solutions that grow with you | 01-May-2018 | Application Note

Viral diseases like rabies, rotavirus and influenza are causing many deaths worldwide, resulting in a strong demand for more productive manufacturing techniques...

Nifty Biosimilar

Nifty Biosimilar

UGA Biopharma | 13-Mar-2018 | Research Study

Aflibercept (Zaltrap®) is a recombinant fusion protein with complex post-translational modifications. Therefore deep understanding of biosimilar development...

Featured eBook: Complex Protein Production

Featured eBook: Complex Protein Production

Catalent Pharma Solutions | 06-Mar-2018 | Technical / White Paper

Download the eBook written by Catalent experts to learn about innovative products and techniques for scale-up of complex biologics, get optimal cell culture...

Related suppliers